BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150 AND Prognosis
3 results:

  • 1. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
    Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
    Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Opportunity of Precision Medicine for breast cancer With Context-Sensitive Tumor Suppressor Maspin.
    Bernardo MM; Dzinic SH; Matta MJ; Dean I; Saker L; Sheng S
    J Cell Biochem; 2017 Jul; 118(7):1639-1647. PubMed ID: 28262971
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy.
    Villarreal-Garza C; Bargallo-Rocha JE; Soto-Perez-de-Celis E; Lasa-Gonsebatt F; Arce-Salinas C; Lara-Medina F; Reynoso-Noverón N; Matus-Santos J; Cabrera P; Alvarado-Miranda A; Mohar A
    Breast Cancer Res Treat; 2016 Jun; 157(2):385-394. PubMed ID: 27189008
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.